UNITAID is engaged in finding new ways to prevent, treat and diagnose HIV/AIDS, tuberculosis and malaria more quickly, more cheaply and more effectively.  It takes game-changing ideas and turns them into practical solutions that can help accelerate the end of the three diseases. Established in 2006 by Brazil, Chile, France, Norway and the United Kingdom to provide an innovative approach to global health, UNITAID plays an important part in the global effort to defeat HIV/AIDS, tuberculosis and malaria, by facilitating and speeding up the availability of improved health tools, including medicines and diagnostics.

UNITAID identifies health solutions that show promise and invests in them to establish their viability so that partner organisations can then make them widely available.

By helping to fast-track access and reduce costs of new more effective medicines, technologies and systems UNITAID can maximize the impact of every dollar spent to overcome  these lethal diseases.

Many innovations championed by UNITAID and carried forward by our partners have had a big impact. Nearly 13 million people living with HIV are now on antiretroviral treatment, up from just 1.6 million in 2006, largely through a tenfold price reduction in medicines; there has been a 30 per cent year-on-year increase in detection of drug resistant TB in 2014, mostly due to the expanded use of innovative diagnostics; and malaria mortality has been halved since 2000, through better access to effective anti-malarial treatments and preventative measures such as mosquito nets.